Should You Believe The Monster Yields At GlaxoSmithKline plc And BP plc?


A flurry of dividend cuts across the FTSE 100 has caused investors to become increasingly sceptical over the payout forecasts for many of Britain’s leading blue-chips.

Medicines giant GlaxoSmithKline (LSE: GSK) and oil mammoth BP (LSE: BP) are two such stocks that have come under rising scrutiny from income chasers. But are these concerns truly merited?

If you want to find out, continue reading...


Source: The Motley Fool

10 Safe Dividend Stocks for the Second Quarter

These stocks have been paying their shareholders for a long time With the U.S. stock market fresh off its first quarterly loss si...